US 10485829
Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
granted A61KA61K35/12A61P
Quick answer
US patent 10485829 (Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells) held by Astellas Institute for Regenerative Medicine expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K35/12, A61P, A61P27/02